BB

Ben Bergo

Chief Executive Officer

Visus Therapeutics, Inc.

Seattle, Washington


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Visus Therapeutics, Inc.
Industry
research
Employees
61.0
Seniority
C suite
Annual Revenue
320000.0
Total Funding
126000000.0
Latest Funding
Series A

Technologies

Outlook Amazon AWS Cloudflare DNS Microsoft Office 365 WP Engine Greenhouse.io Barracuda Networks Mobile Friendly Google Tag Manager Typekit Vimeo Google Font API QuickBooks Remote AI

Keywords

presbyopia ophthalmology optometry eye health glaucoma macular degeneration dry eye disease amd ocular surface disease regenerative medicine biotechnology research biopharmaceutical cataracts geographic atrophy ocular health eye therapy vision restoration clinical development eye care ophthalmic drugs brimochol injectable therapy microdosing novel therapies patient-centric chronic eye conditions vision impairment innovative pipeline optical health maintenance of vision pupil-modulating drops eye drops disease mechanisms treatment options drug approval clinical trials sight loss prevention patient solutions combination therapies fda-approved retinal health vision restoration therapies ophthalmic indications topical treatment non-surgical options new chemical entities side effect mitigation long-acting treatments visual acuity improvement near vision treatment of presbyopia cell-based therapy treatment of geographical atrophy restoration of vision targeted therapy eye care professionals comprehensive therapeutics health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans